ORGANOGENESIS HOLDINGS INC. Operating Lease Right-of-Use Assets
ORGANOGENESIS HOLDINGS INC. (ORGO) had Operating Lease Right-of-Use Assets of $49.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $49.91M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $53.74M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $55.75M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $33.30M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $49.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $53.74M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $55.75M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $33.30M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $35.26M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $36.76M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $37.11M 10-K · filed 2026-02-26 |
| 2024-09-30 | $34.94M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $36.57M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $38.62M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $40.12M 10-K · filed 2025-02-27 |
| 2023-09-30 | $42.36M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $43.54M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $42.84M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $43.19M 10-K · filed 2024-02-29 |
| 2022-09-30 | $45.37M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $45.86M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $47.47M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $49.14M 10-K · filed 2023-03-01 |
| 2021-09-30 | $26.52M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $26.53M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.71M 10-Q · filed 2021-05-11 |
| 2021-01-01 | $13.53M 10-K · filed 2022-03-01 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |